Summary of Talazoparib Instructions and Usage

Talazoparib is an oral PARP (polyADP ribose polymerase) Inhibitors are mainly used to treat breast cancer patients carrying BRCA1 or BRCA2 gene mutations, especially advanced or metastatic breast cancer. The drug achieves therapeutic effects by inhibiting the DNA repair mechanism in cancer cells and inducing cancer cell death. The following is a summary of the instructions and usage of talazoparib.

Drug ingredients and indications

The active ingredient of talazoparib isTalazoparib, which is a PARP enzyme inhibitor, mainly by blocking the intracellular activity of cancer cellsPARPenzyme interferes with the repair of DNA single-strand breaks, leading to the accumulation of DNA damage in cancer cells, thereby inducing cancer cell apoptosis. It is suitable for patients with locally advanced or metastatic breast cancer who carry harmful BRCA1/2 gene mutations, especially adult patients who require further treatment after hormone therapy and at least one chemotherapy regimen.

Usage and dosage

Talazoparib is an oral medication. It is usually recommended to take it once a day at a dose of 1 mg. Patients should take it at the same time every day, with food or on an empty stomach. The tablet should be swallowed whole and should not be broken, crushed or chewed. Treatment should be continued until disease progression or unacceptable toxicity occurs.

Patients should strictly abide by the doctor's medication instructions during medication and are not allowed to adjust the dosage or stop medication at will. For patients with renal insufficiency, doctors may adjust the dose based on specific circumstances. Patients with hepatic impairment should use it with caution and monitor and adjust dosage if necessary.

Adverse reactions and monitoring

Common adverse reactions of talazoparib include anemia, fatigue, nausea, alopecia, leukopenia and thrombocytopenia. These hematological toxicities are caused by the drugs affecting normal bone marrow cells by inhibiting DNA repair. Patients need to undergo regular blood tests, including routine blood tests and liver and kidney function monitoring, in order to detect and deal with side effects in a timely manner.

Some patients may experience gastrointestinal discomfort, such as vomiting, diarrhea, etc., which can usually be relieved by adjusting their diet or taking symptomatic drugs. A very small number of patients may experience severe allergic reactions or liver function damage. If symptoms such as rash, jaundice, severe fatigue, etc. occur, they should seek medical treatment in time.

Precautions and taboos

Talazoparib is contraindicated in patients who are allergic to the ingredients of this product. Pregnant and lactating women should avoid its use because this drug may have serious effects on the fetus and infant. Effective contraceptive measures must be taken during use and should be continued for a period of time after treatment to avoid pregnancy.

Patients should avoid concomitant use with other myelosuppressive drugs while taking talazoparib to reduce the risk of severe hematologic toxicity. If the patient has severe liver and kidney dysfunction, the drug should be used with caution or the dosage should be adjusted under the guidance of a doctor.

In general, talazoparib is a precision treatment drug for BRCA gene-mutated advanced breast cancer and has significant anti-tumor effects. It induces tumor cell death and effectively delays disease progression by inhibiting the DNA repair mechanism of cancer cells. When using it, you should strictly follow the doctor's instructions, pay attention to the adverse reactions of the drug, especially the toxic reactions of the blood system, and monitor relevant indicators regularly. Patients should maintain close communication with their doctors during medication to ensure the safety and effectiveness of treatment.

Reference materials:https://www.talzenna.com/